1. Home
  2. BLCO vs SAIC Comparison

BLCO vs SAIC Comparison

Compare BLCO & SAIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLCO
  • SAIC
  • Stock Information
  • Founded
  • BLCO 1853
  • SAIC 1969
  • Country
  • BLCO Canada
  • SAIC United States
  • Employees
  • BLCO N/A
  • SAIC N/A
  • Industry
  • BLCO Ophthalmic Goods
  • SAIC EDP Services
  • Sector
  • BLCO Health Care
  • SAIC Technology
  • Exchange
  • BLCO Nasdaq
  • SAIC Nasdaq
  • Market Cap
  • BLCO 4.4B
  • SAIC 4.9B
  • IPO Year
  • BLCO 2022
  • SAIC N/A
  • Fundamental
  • Price
  • BLCO $11.70
  • SAIC $103.65
  • Analyst Decision
  • BLCO Hold
  • SAIC Buy
  • Analyst Count
  • BLCO 13
  • SAIC 9
  • Target Price
  • BLCO $15.63
  • SAIC $130.44
  • AVG Volume (30 Days)
  • BLCO 578.9K
  • SAIC 754.3K
  • Earning Date
  • BLCO 07-30-2025
  • SAIC 06-02-2025
  • Dividend Yield
  • BLCO N/A
  • SAIC 1.44%
  • EPS Growth
  • BLCO N/A
  • SAIC N/A
  • EPS
  • BLCO N/A
  • SAIC 7.14
  • Revenue
  • BLCO $4,829,000,000.00
  • SAIC $7,509,000,000.00
  • Revenue This Year
  • BLCO $6.97
  • SAIC $4.64
  • Revenue Next Year
  • BLCO $5.48
  • SAIC $2.99
  • P/E Ratio
  • BLCO N/A
  • SAIC $14.45
  • Revenue Growth
  • BLCO 11.94
  • SAIC 3.39
  • 52 Week Low
  • BLCO $10.45
  • SAIC $94.68
  • 52 Week High
  • BLCO $21.69
  • SAIC $156.34
  • Technical
  • Relative Strength Index (RSI)
  • BLCO 45.65
  • SAIC 35.86
  • Support Level
  • BLCO $11.44
  • SAIC $103.51
  • Resistance Level
  • BLCO $12.70
  • SAIC $106.71
  • Average True Range (ATR)
  • BLCO 0.36
  • SAIC 3.11
  • MACD
  • BLCO 0.01
  • SAIC 0.06
  • Stochastic Oscillator
  • BLCO 30.07
  • SAIC 49.82

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

About SAIC SCIENCE APPLICATIONS INTERNATIONAL CORPORATION

Science Applications International Corp provides technical, engineering, and enterprise IT services mainly to the U.S. government. Specifically, it offers end-to-end solutions spanning the design, development, integration, deployment, management and operations, sustainment, and security of the customer's entire IT infrastructure. The company has two reportable segments which include Defense and Intelligence and the Civilian segment. Maximum revenue is generated from its Defense and Intelligence segment, which provides a diverse portfolio of national security solutions to the Department of Defence (DoD) and the Intelligence Community of the United States Government. The Civilian segment provides solutions to the civilian markets, encompassing federal, state, and local governments.

Share on Social Networks: